Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 3
Submit an article Journal homepage
34
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and Toxicity of Liposomal Daunorubicin Included in PVABEC Regimen for Aggressive NHL of the Elderly

Giulia Cervetti Department of Oncology, Division of Hematology, University of Pisa, Pisa, Italy
,
Francesco Caracciolo Department of Oncology, Division of Hematology, University of Pisa, Pisa, Italy
,
Nadia Cecconi Department of Oncology, Division of Hematology, University of Pisa, Pisa, Italy
,
Antonio Azzarà Department of Oncology, Division of Hematology, University of Pisa, Pisa, Italy
&
Mario Petrini Department of Oncology, Division of Hematology, University of Pisa, Pisa, Italy
Pages 465-469 | Published online: 01 Jul 2009

  • Martelli, M., Guglielmi, C., Coluzzi, S., Awisati, G., Amadori, S., Giovannini, M., Torromeo, C. and Mandelli, F. (1993) "A prospective study of a new weekly Chemotherapic regimen for elderly aggressive non-Hodgkin's lymphoma", Journal of Clinical Oncology 11, 2362-2369.
  • Caracciolo, E, Petrini, M., Capochiani, E., Papineschi, E and Grassi, B. (1993) "Third generation chemotherapy with P-VABEC for aggressive non-Hodgkin's lymphomas of the elderly", Leukemia & Lymphoma 11, 115-118.
  • Carccciolo, E, Petrini, M., Capochiani, E, Papineschi, E, Carulli, G. and Grassi, B. (1994) "Alternating chemotherapy regimen (P-VABEC) for intermediate and high grade non-Hodgkin's lymphoma of the middle aged and elderly", Hematology Oncology 12, 185-192.
  • Caracciolo, E, Capochiani, E, Papineschi, E and Petrini, M. (1997) "Consolidation therapy with Idarubicin, Cisplatin and Prednisone (CIP) after P-VABEC regimen in the treatment on intermediate and high grade non-Hodgkin's lymphoma of the elderly", Leukemia A Lymphoma 24, 355-361.
  • Martelli, M., Caracciolo, E, Pernotti, A., De Sanctis, V, Petrini, M., Andriani, A., Luzi, G., Giovannini, M., Iannitto, E., Montanaro, M., Rizzo, M. and Mandelli, E (2002). "Cisplatinum, Idarubicin, Prednisone (CIP) as consolidation therapy foe elderly NHL patients after standard P-VABEC regimen. An Italian multicenter randomised study. (Abs)" VIII International Conference On Malignant Lymphoma, Lugano Switzerland 12-15 June 2002.
  • Zinzani, P.L., Storti, S., Zaccaria, A., Moretti, L., Magagnali, M., Pavone, E., Gentilizi, P., Guardiani, L., Gobi, M., Fattori, PP., Falini, B., Lauta, V.M., Bendandi, M., Gherlinzoni, E, De Renzo, A., Zaja, E, Mazza, P., Volpe, E, Bocchia, M., Aitini, E., Tabanelli, M., Leone, G. and Tura, S. (1999) "Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients", Blood 94, 33-38.
  • Bertini, M., Freilone, R., Vitolo, U., Botto, B., Ciotti, R., Cinieri, S., Di Nota, A., Di Vito, E, Levis, A., Orsucci, L, Pini, M., RotaScalabrini, D., Todeschini, G. and Resegotti, L. (1996) "The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intense multidrug regimen", Leukemia Lymphoma 22, 483-493.
  • Presant, C.A., Proffitt, R.T., Turner, A.F., Williams, L.E., Winsor, D., Werner, J.L., Kennedy, P., Wisemand, C., Gala, K., McKenna, R.J., Smith, I.D., Bouzaglou, S.A., Callahan, R.A., Baldeschwieler, I.D. and Crossley, R. J. (1988) "Successful imaging of human cancer with indium-111-labeled phospholipid vesicles", Cancer (Philadelphia) 62, 905-911.
  • Turner, A.F., Presant, C.A., Proffitt, R.T., Williams, L.E., Winsor, D.W. and Werner, I.L. (1988) "In-111-labeled liposomes: dosimetry and tumor depiction", Radiology 166, 761-765.
  • Williams, L.E., Duda, R.B., Proffitt, R.T., Beatty, I.D., Wong, J.Y.C., Shivery, J.E. and Paxton, R.I. (1988) "Tumor uptake as a function of tumor mass: a mathematic model", Journal of Nuclear Medicine 29, 103-109.
  • Warren, B.A. (1979) "The vascular morphology of tumors", In: Peterson, H.-I., ed, Tumor Blood Circulation: Angiogenesis, Vascular Morphology, and Blood Flow of Experimental and Human Tumor (CRC Press. Inc., Boca Raton, FL), pp 1 -47.
  • Hwang, K.J., Padki, M.M., Chow, D.D., Essien, H.E., Lai, J.Y. and Beaumier, R.L. (1987) "Uptake of small liposomes by nonreticuloendothelial tissues", Biochemical Biophysical Acta 901, 88-96.
  • Allen, T.M., Austin, G.A., Chonn, A., Lin, L. and Lee, K.C. (1991) "Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size", Biochemical Biophysical Acta 1061, 56-64.
  • Forssen, E.A., Coulter, D.M. and Proffitt, R.T. (1992) "Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors", Cancer Research 52, 3255-3261.
  • Present, C.A., Blaynely, D., Proffitt, R.T., Turner, A.F., Williams, L.E., Nadel, H.L, Kennedy, P., Wiseman, C., Gala, K., Crossley, R.J., Preiss, S.J., Ksionski, G.E. and Presant, S.L. (1990) "Preliminary report: Kaposi sarcoma and lymphoma in AIDS with indium-111-labeled liposomes", Lancet 335, 1307-1309.
  • Forssen, E.A. and Ross, M.E. (1994) "Daunoxome® treatment of solid tumors: preclinical and clinical investigations", Journal of Liposome Research 4, 481-512.
  • Forssen, E.A., Malè-Brune, R., Adler-Moore, I.P., Lee, M.J.A., Schmidt, P.G., Krasieva, T.B., Schimizu, S. and Tromberg, B.I. (1996) "Fluorescence imaging studies for the disposition of daunorubicin liposomes (daunoxome) within tumor tissue", Cancer Research 56, 2066-2075.
  • Verdonck, L.F., Lokhorst, H.M., Rovers, DJ. and van Beugten, H.G. (1998) "Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunorubicin: implications for liposome-encapsulated daunorubicin", Leukemia Research 22, 249-256.
  • Michieli, M., Damiani, M., Ermacora, A., Masolini, P., Michelutti, A., Michelutti, T., Russo, D., Pea, F. and Baccarani, M. (1999) "Liposome-encapsulated daunorubicin for PGP-related multidrug resistance", British Journal of Haematology 106, 92-99.
  • Presant, C.A., Scolaro, M., Kennedy, P., Blayney, D.W., Flanagan, B., Lisak, J. and Presant, J. (1993) "Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma", Lancet 341,1242-1243.
  • Money-Kyrle, J.F., Bates, F., Ready, I., Gazzard, B.G., Phillips, R.H. and Boag, F.C. (1993) "Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study", Clinical Oncology 5, 367-371.
  • Gills, P.S., Espina, B.M., Muggia, F., Cabriales, S., Tulpule, A., Esplin, I.A., Liebman, H.A., Forssen, E., Ross, M.E. and Levine, A.M. (1995) "Phase VU clinical and pharmacokinetic evaluation of liposomal daunorubicin", Journal of Clinical Oncology 13, 996-1003.
  • Gill, P.S., Wernz, I., Scadden, D.T., Cohen, P., Mukwaya, G.M., von Roenn, I.H., Jacobs, M., Kempin, S., Silverberg, I., Gonzales, G., Rarick, M.U., Myers, A.M., Shepherd, F., Sawka, C, Pike, M.C. and Ross, M.E. (1996) "Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma", Journal of Clinical Oncology 14, 2353-2364.
  • Rosenthal, E., Poizot-Martin, I., Saint-Marc, T., Spano, I.P. and Cacoub, P. (2002) "Phase IV study of liposomal daunorubicin (dauoxome) in AIDS-related Kaposi sarcoma", American Journal of Clinical Oncology 25, 57-59.
  • Cortes, I., O'Brien, S., Estey, E., Giles, P., Rearing, M. and Kantarjian, H. (1999) "Phase I study of liposomal daunorubicin in patients with acute leukemia", Investigational New Drugs 17, 81-87.
  • Cortes, I., Estey, E., O'Brien, S., Giles, F., Shen, Y, Koller, C., Heran, M., Thomas, D., Rearing, M. and Katarjian, H. (2001) "High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia", Cancer 92, 7-14.
  • Passas, A., Buffels, R., Anagnostopoulos, A., Gacos, E., Vadikolia, C., Haloudis, P. and Kaloyannidis, P. (2002) "Safety and easily efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study", British Journal of Haematology 116, 308-315.
  • Richardson, D.S., Kelsey, S.M., Johnson, S.A., Tighe, M., Cavenagh, I.D. and Newland, A.C. (1997) "Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphoma", Investigational New Drugs IS, 247-253.
  • Pratt, G., Wiles, M.E., Rawstron, A.C., Davies, P.E., Fenton, I.A., Proffitt, I.A., Child, I.A., Smith, G.M. and Morgan, G.I. (1998) "Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma", Hematology Oncology 16, 47-55.
  • Flinn, L.W., Goodman, S.N., Post, L., Jamison, I., Miller, C.B., Gore, S., Diehl, L., Willis, C., Ambinder, R.F. and Byr, I.C. (2000) "A dose-finding study of liposomal daunorubicin with CVP (COPX) in advanced NHL", Annals of Oncology 11, 691-695.
  • Tsiara, S.N., Kapsali, E., Christou, L., Panteli, A., Pritsvelis, N. and Bourantas, K.L. (2000) "Administration of a modified chemotherapeutic regimen containing vincristine, liposomal daunorubicin and dexamethasone to multiple myeloma patients: preliminary data", European Journal of Haematology 65, 118-122.
  • Dabaja, B.S., O'Brien, S.M., Kantarjian, H.M., Cortes, I.E., Thoma, D.A., Albitar, M., Schiene, E.S., Faderl, S., Sarris, A., Rearing, M.I. and Giles, F.I. (2001) "Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoxome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome", Leukemia & Lymphoma 42, 329-337.
  • Tulpule, A., Rarick, M.U., Kblitz, I., Bernstein, I., Myers, A., Buchanan, L.A., Espina, B.M., Traynor, A., Letzer, I., Justice, G.R., McDonald, D., Roberts, L., Boswell, W, Nathwani, B. and Levine, A.M. (2001) "Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma", Annals of Oncology 12, 457-462.
  • Cheson, B.D., Horning, S.I., Coiffier, B., Shipp, M.A., Fisher, R.I., Connors, I.M., Lister, T.A., Vose, I., Grillo-Lopez, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N.L., Armitage, J.O., Carter, W., Hoppe, R. and Canellos, G.P. (1999) "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas", Journal of Clinical Oncology 17, 1244-1253.
  • World Health Organization (1979) Handbook for Reporting Results of Cancer Treatment WHO Offset Publication, (WHO, Geneva) 48.
  • Kaplan, E. and Meier, P. (1958) "Non parametric estimation from incomplete observations", Journal of American Statisticians Association 53,457-481.
  • Forssen, E.A. and Tokès, Z.A. (1983) "Attenuation of dermal toxicity of doxorubicin by liposome encapsulation", Cancer Treatment of Reports 67, 481-484.
  • Balazsovits, J.A.E., Mayer, L.D., Bally, M.B., Cullis, P.R., McDonell, M., Ginsberg, R.S. and FaIk, R.E. (1989) "Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and Antitumor efficacy of doxorubicin", Cancer Chemotherapy and Pharmacology 23, 81-86.
  • Pfreundschuh, L., Trumper, M., Schmitz, N., Glass, B., Hasenclever, D., Engert, A., Rudolphy, C., Illiger, J., Hossfeld, D. and Loffler, M. (2001). "Two-weekly CHOP with G-CSF: new standard regimens for elderly patients with aggressive non-Hodgkin's lymphoma." Sixth Meeting of the European Haematology Association, Frankfurt, Germany/June 21-24, 2001.
  • Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdllah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F. and Gisselbrecht, C. (2002) "Chop chemotherapy plus Rituximab compared with Chop alone in elderly patients with diffuse large-B-cell lymphoma", The New England Journal of Medicine 346, 235-242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.